Recruiting Geographic Atrophy Studies in Milwaukee
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Cohort 1 \[CLOSED\] Study treatment involves two segments: (1) Induction Immunotherapy segment with pembrolizumab monotherapy every 3 weeks until irRECIST PD and (2) Combination Therapy segment. Nab-p...
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovi...
About Geographic Atrophy Clinical Trials in Milwaukee
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 2 geographic atrophy clinical trials recruiting participants in Milwaukee, WISCONSIN. These studies are seeking a combined 78 participants. Research is being sponsored by Harry H Yoon, New York Medical College. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Milwaukee — FAQ
Are there geographic atrophy clinical trials in Milwaukee?
Yes, there are 2 geographic atrophy clinical trials currently recruiting in Milwaukee, WISCONSIN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Milwaukee?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you about next steps.
Are clinical trials in Milwaukee free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Milwaukee studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 2 active trials in Milwaukee are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated March 2, 2026 from ClinicalTrials.gov